Philip Christopher Buxton

This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Eagle Pharmaceuticals, Inc., Scidose Pharma LLC, Scidose, LLC. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Christopher Buxton. Retrieved from https://idiyas.com/inventor/philip-christopher-buxton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 9)

% Patents Active = 90.5

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 139(Granted Patents)

Location History:

Harlow, GB (2006)
Essex, GB (2017)
Great Dunmow, GB (2002 - 2018)
Uxbridge, GB (2019 - 2024)

Company Filing History:

12 out of 38

Eagle Pharmaceuticals, Inc.

Smithkline Beecham Corporation

patents

5. 1 out of 1

Auromedics Pharma LLC

patent

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Bendamustine

Vancomycin

Cyclophosphamide

Pemetrexed

Ulcerative Colitis

Thiazolidinedione

Pharmaceutical Compositions

Stability

Liquid Concentrate

Flavor Vehicle

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350257 - Formulations of bendamustine (2025-07-08),

2. 12343333 - Formulations of bendamustine (2025-07-01),

3. 12220441 - Formulations of vancomycin (2025-02-11),

4. 12138248 - Formulations of bendamustine (2024-11-12),

5. 11872214 - Formulations of Bendamustine (2024-01-16),

6. 11844783 - Formulations of bendamustine (2023-12-19),

7. 11497789 - Formulations of vancomycin (2022-11-15),

8. 11103483 - Formulations of bendamustine (2021-08-31),

9. 10864250 - Formulations of vancomycin (2020-12-15),

10. 10376559 - Formulations of vancomycin (2019-08-13),

11. 10010533 - Formulations of bendamustine (2018-07-03),

12. 9662342 - Formulations of cyclophosphamide liquid concentrate (2017-05-30),

13. 9655898 - Pharmaceutical compositions containing pemetrexed having extended storage stability (2017-05-23),

14. 9572797 - Formulations of bendamustine (2017-02-21),

15. 9572796 - Formulations of bendamustine (2017-02-21),

Title: Inventor Philip Christopher Buxton

Introduction: Philip Christopher Buxton is a renowned inventor based in Great Dunmow, GB, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Philip Christopher Buxton holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his commitment to creating solutions for a more sustainable future.

Career Highlights: With a career spanning over two decades, Philip Christopher Buxton has worked with leading research institutions and companies to develop cutting-edge technologies that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Philip Christopher Buxton has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Philip Christopher Buxton's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.